Daily Trade

Few stock sectors offer soar-or-sink possibilities like biotechnology stocks do. If you’re in the market for an intriguing biotech pick and can manage high risk, take a look at Actinium Pharmaceuticals (NYSEAMERICAN:ATNM)stock. Actinium Pharmaceuticals develops targeted radiotherapies for refractory cancer cases. By “refractory,” I mean that Actinium Pharmaceuticals focuses on helping patients meaningfully improve their
0 Comments
Snowflake (NYSE:SNOW), which specializes in software for cloud-based data warehousing, was recently overvalued. I tried to warn investors about Snowflake’s trailing price-to-earnings ratio and suggested that SNOW stock was vulnerable to a pullback. That pullback came to pass, but it’s still not the right time to take a share position. Sure, Snowflake as an artificial intelligence
0 Comments
Editor’s note: “AI Stocks: Growing Wealth in the Dot-Com Boom 2.0″ was previously published in February 2024. It has since been updated to include the most relevant information available. Believe it or not, you’re living through a modern version of the 1990s Dot-Com Boom. This time, it’s not the internet but AI technology that’s poised
0 Comments
Everyone might be talking about the stock performance of Nvidia (NASDAQ:NVDA) last year but Super Micro Computer (NASDAQ:SMCI) stock blew away the chipmaker. SMCI stock is up 1,200% compared to the measly tripling in value by Nvidia.  The manufacturer of servers, networks, storage solutions, workstations and more optimized for artificial intelligence (AI) has gotten an
0 Comments
Google and YouTube parent company Alphabet (NASDAQ:GOOG, NASDAQ:GOOGL) is a Magnificent Seven or “Mag-7″ member, but GOOG stock hasn’t been the most magnificent performer lately. We’re still assigning the stock a “B” grade, however, as Alphabet can still offer good value to its shareholders. Alphabet’s Google is, of course, a dominator in the U.S. search-engine market. Plus, the
0 Comments